GR3035386T3 - Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum. - Google Patents

Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum.

Info

Publication number
GR3035386T3
GR3035386T3 GR20010400213T GR20010400213T GR3035386T3 GR 3035386 T3 GR3035386 T3 GR 3035386T3 GR 20010400213 T GR20010400213 T GR 20010400213T GR 20010400213 T GR20010400213 T GR 20010400213T GR 3035386 T3 GR3035386 T3 GR 3035386T3
Authority
GR
Greece
Prior art keywords
cell protein
clara cell
pharmaceutical preparation
diagnosticum
medicament
Prior art date
Application number
GR20010400213T
Other languages
English (en)
Inventor
Ley Marc Jozef Philemon De
Original Assignee
Ley Marc Jozef Philemon De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ley Marc Jozef Philemon De filed Critical Ley Marc Jozef Philemon De
Publication of GR3035386T3 publication Critical patent/GR3035386T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR20010400213T 1993-03-15 2001-02-07 Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum. GR3035386T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE9300242A BE1006919A3 (nl) 1993-03-15 1993-03-15 Farmaceutisch preparaat op basis van clara celeiwit cc10, en het gebruik daarvan als geneesmiddel en diagnosticum.

Publications (1)

Publication Number Publication Date
GR3035386T3 true GR3035386T3 (en) 2001-05-31

Family

ID=3886902

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010400213T GR3035386T3 (en) 1993-03-15 2001-02-07 Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum.

Country Status (8)

Country Link
EP (1) EP0617965B1 (el)
AT (1) ATE197548T1 (el)
BE (1) BE1006919A3 (el)
DE (1) DE69426275T2 (el)
DK (1) DK0617965T3 (el)
ES (1) ES2152285T3 (el)
GR (1) GR3035386T3 (el)
PT (1) PT617965E (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6509316B2 (en) * 1995-03-07 2003-01-21 George Washington University Pharmaceutical compositions, methods, and kits for treatment and diagnosis of lung cancer
US6255281B1 (en) 1997-05-28 2001-07-03 Claragen, Inc. And U.S. Government Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
US7122344B2 (en) 1997-05-28 2006-10-17 Claragen, Inc. Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
US20060281681A1 (en) 1997-05-28 2006-12-14 Pilon Aprile L Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
WO2000072868A2 (en) * 1999-06-01 2000-12-07 Prendergast Patrick T Peptides for therapeutic use
US9394349B2 (en) 2013-03-15 2016-07-19 Therabron Therapeutics, Inc. Modification and compositions of human secretoglobin proteins
WO2023212398A1 (en) * 2022-04-29 2023-11-02 Apc Research Assets Llc Secretoglobins for suppression of antibody responses

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266562A (en) * 1987-11-19 1993-11-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-inflammatory agents

Also Published As

Publication number Publication date
ATE197548T1 (de) 2000-12-15
DE69426275D1 (de) 2000-12-21
PT617965E (pt) 2001-03-30
EP0617965A1 (en) 1994-10-05
ES2152285T3 (es) 2001-02-01
BE1006919A3 (nl) 1995-01-24
EP0617965B1 (en) 2000-11-15
DE69426275T2 (de) 2001-06-07
DK0617965T3 (da) 2001-02-05

Similar Documents

Publication Publication Date Title
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
IE891542L (en) Peptides having t cell helper activity
AU2673095A (en) {a}-annelated pyrrole derivatives and pharmaceutical use thereof
SI0820303T1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES
GR3035386T3 (en) Pharmaceutical preparation based on Clara cell protein CC10, and it's use as medicament and diagnosticum.
NZ330944A (en) Peptide derivatives
CA2225788A1 (en) Therapeutic agents and autoimmune diseases
ZA922910B (en) Heterocylic pharmaceutical compounds preparation and use
CZ91995A3 (en) Gestagen-active 19,11-bridged 4-esterenes, process of their preparation and intermediate for preparing thereof
AU4633097A (en) Peptide analogues containing a 7-membered lactam ring
AU5909596A (en) Synthetic peptides and pharmaceutical compositions comprising them
IL106065A0 (en) Synthetic peptides for the treatment of myasthenia gravis and compositions comprising them
TW261605B (el)
IE873231L (en) Medicaments
EP0651741A1 (en) DERIVATIVES OF N? G -MONOMETHYL-L-ARGININE HYDROCHLORIDE AND THEIR USE IN THE TREATMENT OF SEPTIC SHOCK.
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
DK0704219T3 (da) Anvendelse af faktor for osteoblastisk celledeling
Vallejo et al. Resolution of cyclosporine-induced gingival hyperplasia resistant to azithromycin by switching to tacrolimus
IL100128A0 (en) Pharmaceutical compositions containing an imidazobenzodiazepine
IT1262567B (it) Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia.
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
IT1276706B1 (it) Bicarbonati di derivati della 2,6-dimetilanilina, loro uso in terapia e composizioni farmaceutiche che li comprendono
TW333453B (en) Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ATE58533T1 (de) Neue kristallmodifikation des 3-methoxy-4-(4'aminobenzolsufonamido)-1,2,5-thiadiazols, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen.

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees